iRhythm (Nasdaq: IRTC) announced this week that it has completed its $287.5 million acquisition of cardiac monitoring tech company VitalConnect. In a news release posted yesterday, iRhythm CEO Quentin Blackford described the deal close as an important milestone as the San Francisco–based company evolves past being a wearable heart patch monitor company to providing a […]
VitalConnect
VitalConnect raises $100M for biosensor tech for cardiac monitoring
VitalConnect announced today that it closed a $100 million financing through a combination of equity and debt capital. New investor Ally Bridge Group led the financing, with significant participation coming from existing investors. Those include EW Healthcare Partners, MVM and Revelation Partners. Trinity Capital provided the debt financing. In conjunction with the financing, the company […]
VitalConnect wins Frost & Sullivan innovation award for patient monitoring device
Frost & Sullivan today recognized VitalConnect with its 2022 North America New Product innovation award for its biosensor technology. VitalConnect’s biosensor monitors patients and detects multiple health problems. According to a news release, the platform reduced hospital workloads by enabling home monitoring. Patients who prefer to move freely could use the comfortable, state-of-the-art cardiac monitoring […]
